a:["$","html",null,{"lang":"en","children":[["$","$Lb",null,{"GA_MEASUREMENT_ID":"G-84TRH311NW"}],["$","body",null,{"className":"flex flex-col bg-gray-light","children":[["$","$Lc",null,{"banners":[{"subText":null,"textArea":"MI:RNA is a veterinary diagnostics company pioneering groundbreaking disease diagnosis technology.","link":null,"linkBehaviour":false,"image":"bannerImage1","_createdAt":"2023-05-28T20:10:44Z","name":"Companion Animal","title":"Revolutionising early diagnosis in animals.","button":"Find out more","_id":"8ee5565c-7e2b-4af0-b65f-df857b985d39"},{"image":"bannerImage2","subText":"*NExtgen Mirna testing with Optimisation","link":"/companion","_id":"bc29bd87-f142-4bd3-b21f-dd80927b2ffe","_createdAt":"2023-06-04T08:19:49Z","name":"NEMO Cardiac Health Screening","title":"NEMO* Cardiac Health Screening","button":"Find out more","textArea":"

Our revolutionary test can identify early-stage heart disease using serum biomarkers and AI modelling.

Follow the link below for more information on NEMO* and our companion animal research.

","linkBehaviour":false},{"link":"/production","_id":"d10ebe3b-56a7-46ce-9d0b-8d893a6b8789","name":"Production Animals","title":"NEMO* Johne’s Disease Screening ","subText":"*NExtgen Mirna testing with Optimisation","textArea":"

We believe using science-based methodologies can unlock the potential to extend life and reduce the suffering of animals, while also contributing to lower emissions and lower costs to farmers.

Follow the link below for more information on our production animal research.

","_createdAt":"2023-05-28T20:14:08Z","image":"bannerImage4","button":"Find out more","linkBehaviour":false}],"lang":"en","nav":{"HomePage":{"title":"MI:RNA Diagnostics","description":"Science led, science approved.","description2":"We’re radically changing how testing is done.","description3":"Founded in 2019, our vision is to change the way approach disease diagnosis to improve patient outcomes. The merits of our technology are scientifically reviewed and proven, winning numerous grants and awards.","PartnersAndCollaborators":{"title":"Partners & Collaborators"},"videoUrl":"https://mirna-video-storage.s3.eu-west-2.amazonaws.com/NewPitchVideo.mp4","Education":{"area1":{"title":"Education materials and research","text":"Learn more about this emerging technology with a free CPD webinar from founder and CEO, Dr. Eve Hanks."},"area2":{"title":"The use of MicroRNAs as biomarkers in heart disease","name":"Dr. Eve Hanks","qualifications":"CEO and Founder BVM&S CertAVP (EM) PhD MRCVS","buttonText":"On-demand CPD","path":"https://docsend.com/view/rxmcrmz9nni6zyz6"}},"Practice":{"title":"Elevate and differentiate your practice.","text":"Our cutting-edge product disrupts conventional care models, and can help strengthen relationships with your clients by helping extend and improve the quality of life of their pets. With a focus on wellness and prevention, our NEMO Companion Animal Test can:","bulletPoints":[{"text":"Offer improved care through enhanced diagnostics"},{"text":"Improve client engagement with treatments and diets"},{"text":"Help elevate your level of patient care"}]},"Awards":{"WES":"Winners 2023
Business to Watch of the Year","EIC":"Seal of Excellence Awarded 2023","Leap":"Part of Cohort #7 - 2023","PetCare":"Winners of Best in Show Spotlight - Berlin 2023","SEdge":"Winners 2020","UA":"Winners 2020","SEnterprise":"Winners 2020","Converge":"Winners 2020 & 2021","UKRI":"Funding Awarded for R&D"},"RDMoreInfoButtons":{"HeaderText":"Follow the links below for more information on our current R&D projects","Companion":{"text":"Companion Animal","path":"/companion"},"ProductionAnimal":{"text":"Production Animal","path":"/production"},"Equine":{"text":"Equine","path":"/equine"}},"Milestones":{"HeaderText":"Milestones and Roadmap","CEOQuote":"We are very proud to have attracted an excellent calibre of experienced investors and new team members during 2022. An extremely successful year for the company. We are now planning some exciting new developments for 2023 and we all are already for the challenge!","Name":"Dr Eve Hanks","RoleText":"Founder & CEO","ButtonText":"Go to News page","path":"#","HexMilestones":[{"DateText":"November 2021","Text":"Launch of first companion animal test"},{"DateText":"2022","Text":"Johne’s Disease R&D Project Pilot Data"},{"DateText":"2023","Text":"Commence Equine R&D Project"},{"DateText":"2023","Text":"Production Animal R&D phase 2"},{"DateText":"2024","Text":"EU & USA Expansion"},{"DateText":"2025","Text":"International expansion"}]}},"AboutPage":{"title":"About","introheader":"We strive to improve the health of animals to extend and improve their quality of life","introtext":"$d","introtext-old":"Founded in 2019, MI:RNA is the first diagnostic testing laboratory to use groundbreaking microRNA technology and artificial intelligence to help detect diseases earlier.","description":"

The routing is internationalized too.

If you're using the default language English, you'll see /about in the browser address bar on this page.

If you change the locale to German, the URL is prefixed with the locale (/de/about).

"},"ContactPage":{"EnquiryTitle":"Submit an enquiry","EnquiryText":"If you are interested in finding out more about our revolutionary new testing technology, or have any other questions for us, then submit an enquiry via the form below and a member of our team will get back to you as soon as possible.","FirstNamePlaceholderText":"First name","LastNamePlaceholderText":"Last name","EmailPlaceholderText":"Please enter your email","MessagePlaceholderText":"Please enter your message","NewsletterPlaceholderText":"Please check the box to subscribe to our newsletter","FormSuccess":"Message sent","FormError":"Oops, Something didnt work!","ContactFormButtonText":"Send","ContactFormButtonTextSending":"Sending...","ContactFormButtonTextSent":"Sent"},"CompanionAnimalPage":{"text":"

Introducing
NEMO* Cardiac Health Screening
for cats & dogs

","buttonText":"Find out more","path":"https://docsend.com/view/ni88wtmdvnq84ch7","buttonBehavior":"_blank","subtext":"*NExtgen Mirna testing with Optimisation","imageArea":{"title":"","text":""},"paperLinkBox":{"text":"Please see the preprint of our research publication","buttonText":"View paper here","buttonLink":"https://doi.org/10.21203/rs.3.rs-3337993/v1","buttonBehavior":"_blank"},"videoUrl":"https://mirna-video-storage.s3.eu-west-2.amazonaws.com/HeartDiseaseVideo.mp4","interestButtonText":"","buttonLink":"","OverviewHeader":"Overview of Projects","ActiveText":"Active","NonActiveText":"In the Pipeline","Overview":[{"project":"Cardiac Disease","status":true},{"project":"Kidney Disease","status":true},{"project":"Progression and Prediction","status":true},{"project":"Osteoarthritis","status":false},{"project":"Cancer","status":false},{"project":"Heartworm","status":false}]},"ProductionAnimalPage":{"text":"

Introducing
NEMO* Johne’s Disease Screening
for cattle

","buttonText":"Find out more","path":"https://docsend.com/view/6k9buthq499rg3ey","buttonBehavior":"_blank","subtext":"*NExtgen Mirna testing with Optimisation","imageArea":{"title":"","text":""},"paperLinkBox":{"text":"Please see the preprint of our research publication","buttonText":"View paper here","buttonLink":"https://doi.org/10.1101/2023.07.07.548088","buttonBehavior":"_blank"},"videoUrl":"https://mirna-video-storage.s3.eu-west-2.amazonaws.com/JohnesDiseaseVideo.mp4","interestButtonText":"Register your interest","buttonLink":"https://forms.gle/re8tSqS9SvMaAXfG7","OverviewHeader":"Overview of Projects","ActiveText":"Active","NonActiveText":"In the Pipeline","Overview":[{"project":"Johne's Disease","status":true},{"project":"Endocarditis","status":true},{"project":"Johne's Disease (sheep & goats)","status":false},{"project":"Tuberculosis","status":false}]},"NewsPage":{"title":"Latest News","PressInfo":"For press enquiries please email:","backButtionText":"Back to news","sourceText":"Source:"},"InvestmentPage":{"InvestmentTitle":"Invest in us","InvestmentText":"

MI:RNA is a highly innovative, award-winning tech start up working to advance animal health.

With a strong first mover advantage in the novel biomarker (miRNAs) space, our female led, passionately gender balanced team is comprised of leading experts with a true entrepreneurial mindset and a diverse range of skills, set to bring this technology to the global market.

MI:RNA has raised a total of $1.9 million including large, non-dilutive Innovate UK grants.

Our pre-seed and seed round investors comprise of strategic Angel investors in the UK, EU and US as well as Mars Petcare in our first VC funding deal.

We are always looking to engage with investors who share our vision and values.

","InvestmentTextSubTitle":"Why invest?","CallRequestForm":{"TitleText":"Request a Meeting","SubTitleText":"Submit your details below and a member of our team will be in touch to arrange a call.","FirstNamePlaceholderText":"First name","LastNamePlaceholderText":"Last name","CompanyPlaceholderText":"Company name","EmailPlaceholderText":"Please enter your email","WorldRegionPlaceholderText":"World region","OtherRegionOptionText":"Other","OtherRegionPlaceholderText":"Please enter your location","MessagePlaceholderText":"Please enter your message","NewsletterPlaceholderText":"Please check the box to subscribe to our newsletter","FormSuccess":"Message sent","FormError":"Oops, Something didnt work!","InvestmentFormButtonText":"Send","InvestmentFormButtonTextSending":"Sending...","InvestmentFormButtonTextSent":"Sent"},"WorldMapText":{"Line1":"~$37B USD Market","Line2":"7% CAGR for Diagnostics"},"LinkBox":{"text":"If you are interested in finding out more then why not book a meeting with our founders:","buttonText":"Request a meeting","buttonLink":"/investment/enquiry","buttonBehavior":"_Self"},"bulletPoints":[{"text":"Disruptive technology with huge impact on animals, people and planet"},{"text":"Significant customer traction in key international markets"},{"text":"A high performing team with a genuine culture of innovation and ingenuity"},{"text":"Clear route to market with global potential"},{"text":"Robust IP strategy with 4 patents pending"}],"timelineData":[{"date":"20211101","title":"","details":"We first validated our revolutionary technology for use in detecting early-stage cardiac disease in cats and dogs, eclipsing current methods."},{"date":"20211201","title":"","details":"The team then began adapting the technology for production animals to improve animal welfare, reduce greenhouse gas emissions and protect consumer safety."},{"date":"20220101","title":"","details":"Through an Innovate UK funded project, we obtained pilot data for our first production animal target, Johne’s Disease in cattle. A major issue globally, desperately in need of an early diagnostic."},{"date":"20230101","title":"","details":"Peer-reviewed scientific publication of cardiac diagnostic performance in mitral valve disease of dogs"},{"date":"20230201","title":"","details":"Obtained international investment from MARS Petcare as part of their highly competitive LEAP accelerator programme."},{"date":"20230301","title":"","details":"Peer-reviewed scientific publication of Johnes disease project preliminary data."},{"date":"20230401","title":"","details":"Building on the success of our Johne’s Disease research, the team have made it through to the final interview stage to win funding from EIC for a large R&D and commercialisation project."},{"date":"20240101","title":"","details":"Our go to market strategy involves distribution through existing laboratory networks with the UK, EU and US as our primary targets."},{"date":"20240201","title":"","details":"We will continue R&D and commercialisation of an early diagnostic for Equine cardiac disease."},{"date":"20250101","title":"","details":"Our ambitious roadmap culminates in having 10 unique test offerings across a range of species and diseases by the end of 2025, showcasing the true potential of our platform technology."}]},"CookieBar":{"BarText":"We use cookies for analytics and site performance but we never collect any personal data","PolicyLink":"Cookie policy","PolicyLinkPath":"/policies/cookie-policy","DeclineButton":"Decline","AllowButton":"Allow Cookies"},"NotFoundPage":{"title":"Page not found","description":"Please double-check the URL or use the navigation to go to a known page."},"LocaleSwitcher":{"label":"Change language","locale":"{locale, select, de {German} en {English} other {Unknown}}"},"Navigation":{"Home":{"title":"Home","path":"/"},"AboutUs":{"title":"About Us","path":"/aboutus"},"Products":{"title":"Diagnostics"},"Companion":{"title":"Companion Animals","path":"/companion"},"Production":{"title":"Production Animals","path":"/production"},"News":{"title":"News","path":"/news"},"ContactUs":{"title":"Contact Us","path":"/contactus"},"Investment":{"title":"Investment","path":"/investment"}},"Footer":{"CopyRight":"MI:RNA Ltd. All rights reserved.","NewsletterButtonText":"Subscribe","NewsletterButtonTextSending":"Sending...","NewsletterButtonTextSent":"Sent","NewsletterText":"Sign up to our mailing list to keep up to date with the latest developments","NewsletterError":"Oops, Sorry something went wrong","NewsletterGoodError":"Already subscribed, Thank you","NewsletterSuccess":"Successfull, Thank you","NewsletterFirstNameField":"First Name","NewsletterLastNameField":"Last Name","NewsletterEmailField":"Enter your email"},"SocialMedia":{"FOJText":"Follow our journey","FacebookLink":"https://www.facebook.com/mirna.diagnostics","TwitterLink":"https://mobile.twitter.com/MIRNA_Diag","InstagramLink":"https://www.instagram.com/mirna_diagnostics/","LinkedInLink":"https://www.linkedin.com/company/mi-rna-diagnostics"},"Team":{"TeamCarouselOne":{"HeaderText":"We’re vets designing for vets.","Text":"We’re veterinary surgeons and research scientists using the latest precision medicine to overcome the challenges we’ve seen in our own careers. Our technology platform provides vets with an additional service offering in a new market, further elevating and differentiating your practice from competitors."},"TeamCarouselTwo":{"HeaderText":"Or connect with a member of our team","Text":""}},"TeamFilterButtons":{"ButtonOne":""},"FormValidationErrors":{"TooShort":"Too Short!","TooLong":"Too Long!","Required":"Required","InvalidEmail":"Invalid email"}}}],["$","main",null,{"className":"w-full","children":[["$","$L8",null,{"parallelRouterKey":"children","segmentPath":["children","(site)","children",["lang","en","d"],"children"],"loading":"$undefined","loadingStyles":"$undefined","hasLoading":false,"error":"$undefined","errorStyles":"$undefined","template":["$","$L9",null,{}],"templateStyles":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","childProp":{"current":["$Le","$Lf",null],"segment":"__PAGE__?{\"lang\":\"en\"}"},"styles":[]}],["$","$L10",null,{"dict":{"BarText":"We use cookies for analytics and site performance but we never collect any personal data","PolicyLink":"Cookie policy","PolicyLinkPath":"/policies/cookie-policy","DeclineButton":"Decline","AllowButton":"Allow Cookies"}}]]}],["$","div",null,{"className":"w-full bg-purple","children":[["$","div",null,{"className":"flex justify-center w-full h-20 px-4 mx-auto align-middle bg-orange md:flex md:px-8","children":["$","div",null,{"className":"flex flex-row items-center justify-around w-full max-w-3xl gap-6 py-4 font-bold text-white md:text-4xl -md:text-sm","children":["Follow our journey",["$","$L11",null,{"href":"https://www.facebook.com/mirna.diagnostics","target":"_blank","children":["$","$L12",null,{"src":{"src":"/_next/static/media/FacebookIcon.6281b42d.svg","height":48,"width":48,"blurWidth":0,"blurHeight":0},"alt":"Facebook Icon","width":42,"height":42}]}],["$","$L11",null,{"href":"https://mobile.twitter.com/MIRNA_Diag","target":"_blank","children":["$","$L12",null,{"src":{"src":"/_next/static/media/TwitterIcon.a2cb2e8a.svg","height":48,"width":48,"blurWidth":0,"blurHeight":0},"alt":"Twitter Icon","width":42,"height":42}]}],["$","$L11",null,{"href":"https://www.instagram.com/mirna_diagnostics/","target":"_blank","children":["$","$L12",null,{"src":{"src":"/_next/static/media/InstagramIcon.1b19798b.svg","height":48,"width":48,"blurWidth":0,"blurHeight":0},"alt":"Instagram Icon","width":42,"height":42}]}],["$","$L11",null,{"href":"https://www.linkedin.com/company/mi-rna-diagnostics","target":"_blank","children":["$","$L12",null,{"src":{"src":"/_next/static/media/LinkedInIcon.e233e968.svg","height":48,"width":48,"blurWidth":0,"blurHeight":0},"alt":"LinkedIn Icon","width":42,"height":42}]}]]}]}],["$","div",null,{"className":"flex flex-col justify-between w-full max-w-screen-xl gap-0 px-2 mx-auto md:flex-row text-gray-light md:px-4","children":[["$","div",null,{"className":"py-2 md:pl-4","children":[["$","$L12",null,{"src":{"src":"/_next/static/media/Logo1.f5eb0af9.svg","height":151,"width":284,"blurWidth":0,"blurHeight":0},"height":125,"alt":"logo"}],["$","div",null,{"className":"mt-4 sm:text-sm text-md","children":[["$","p",null,{"children":"MI:RNA Ltd"}],["$","p",null,{"children":"Scotland's Rural College"}],["$","p",null,{"children":"Room 16"}],["$","p",null,{"children":"Peter Wilson Building Basement"}],["$","p",null,{"children":"The King's Buildings"}],["$","p",null,{"children":"West Mains Road"}],["$","p",null,{"children":"Edinburgh"}],["$","p",null,{"children":"EH9 3JG"}]]}]]}],["$","div",null,{"className":"justify-center h-full py-2 md:py-5 ","children":["$","div",null,{"className":"flex justify-center w-full md:justify-end md:pr-3","children":["$","div",null,{"className":"flex flex-col max-w-[400px]","children":["$","$L13",null,{"dict":{"HomePage":{"title":"MI:RNA Diagnostics","description":"Science led, science approved.","description2":"We’re radically changing how testing is done.","description3":"Founded in 2019, our vision is to change the way approach disease diagnosis to improve patient outcomes. The merits of our technology are scientifically reviewed and proven, winning numerous grants and awards.","PartnersAndCollaborators":{"title":"Partners & Collaborators"},"videoUrl":"https://mirna-video-storage.s3.eu-west-2.amazonaws.com/NewPitchVideo.mp4","Education":{"area1":{"title":"Education materials and research","text":"Learn more about this emerging technology with a free CPD webinar from founder and CEO, Dr. Eve Hanks."},"area2":{"title":"The use of MicroRNAs as biomarkers in heart disease","name":"Dr. Eve Hanks","qualifications":"CEO and Founder BVM&S CertAVP (EM) PhD MRCVS","buttonText":"On-demand CPD","path":"https://docsend.com/view/rxmcrmz9nni6zyz6"}},"Practice":{"title":"Elevate and differentiate your practice.","text":"Our cutting-edge product disrupts conventional care models, and can help strengthen relationships with your clients by helping extend and improve the quality of life of their pets. With a focus on wellness and prevention, our NEMO Companion Animal Test can:","bulletPoints":[{"text":"Offer improved care through enhanced diagnostics"},{"text":"Improve client engagement with treatments and diets"},{"text":"Help elevate your level of patient care"}]},"Awards":{"WES":"Winners 2023
Business to Watch of the Year","EIC":"Seal of Excellence Awarded 2023","Leap":"Part of Cohort #7 - 2023","PetCare":"Winners of Best in Show Spotlight - Berlin 2023","SEdge":"Winners 2020","UA":"Winners 2020","SEnterprise":"Winners 2020","Converge":"Winners 2020 & 2021","UKRI":"Funding Awarded for R&D"},"RDMoreInfoButtons":{"HeaderText":"Follow the links below for more information on our current R&D projects","Companion":{"text":"Companion Animal","path":"/companion"},"ProductionAnimal":{"text":"Production Animal","path":"/production"},"Equine":{"text":"Equine","path":"/equine"}},"Milestones":{"HeaderText":"Milestones and Roadmap","CEOQuote":"We are very proud to have attracted an excellent calibre of experienced investors and new team members during 2022. An extremely successful year for the company. We are now planning some exciting new developments for 2023 and we all are already for the challenge!","Name":"Dr Eve Hanks","RoleText":"Founder & CEO","ButtonText":"Go to News page","path":"#","HexMilestones":[{"DateText":"November 2021","Text":"Launch of first companion animal test"},{"DateText":"2022","Text":"Johne’s Disease R&D Project Pilot Data"},{"DateText":"2023","Text":"Commence Equine R&D Project"},{"DateText":"2023","Text":"Production Animal R&D phase 2"},{"DateText":"2024","Text":"EU & USA Expansion"},{"DateText":"2025","Text":"International expansion"}]}},"AboutPage":{"title":"About","introheader":"We strive to improve the health of animals to extend and improve their quality of life","introtext":"$14","introtext-old":"Founded in 2019, MI:RNA is the first diagnostic testing laboratory to use groundbreaking microRNA technology and artificial intelligence to help detect diseases earlier.","description":"